Goodbye from Nature Reports Stem Cells
We are sad to announce that Nature Reports Stem Cells is closing down. Read more
We are sad to announce that Nature Reports Stem Cells is closing down. Read more
Students from the law and medical schools at Stanford University brought together an impressive group of world-class experts last week to discuss stem cell policy. I’ll describe some (very select) highlights over the next few blogs. Check the site for the Stanford Journal of Law Science & Policy over the next few weeks for powerpoints presentations and audiorecordings. Read more
Earlier this month, the NIH assembled a working group to decide whether currently existing human embryonic stem cell lines confirm with the spirit of guidelines released on July 7. (See Let the vetting begin ) Much of the assessment will center on informed consent procedures. Read more
Cross-posted from In the Field for Elie Dolgin … Read more
The California Institute of Regenerative Medicine has collected a sixth country for its international collaborations. German and Californian scientists will be able to submit joint grants for collaborative projects that focus on immunology. Researchers would, however, be funded by their respective governments. Read more
Listening to scientific talks makes me nervous; it’s so easy to conflate and confuse fast-flowing information. At the most recent meeting of the International Society for Stem Cell Research (ISSCR) this July in Barcelona, I frequently found myself wishing for the slower pace of reading the relevant source material. Others must also want such a list, I reasoned. So, with a great deal of help, and no little cutting and pasting, Nature Reports Stem Cells put it together. Read more
http://www.genengnews.com/specialreports/sritem.aspx?oid=62812927John Gurdon of Cambridge University and Shinya Yamanaka of Kyoto University have been awarded the Lasker prize, also called the American Nobel. (I imagine anyone reading this blog already knows who they are.: frog cloner and cell reprogrammer) … Read more
Alexey Bersenev, whom many of you know from his blog Hematopoiesis, had this additional info on the Russian stem cell IPO reported yesterday by Reuters and blogged by me in the previous post. (Thanks Alexey!) … Read more
Under former US president George W. Bush, fewer than two dozen human embryonic stem cell lines could be studied with federal funding. That number could soon extend into the hundreds, pending ethical review by the US National Institutes of Health. However, research led by Christopher Scott of Stanford University in California shows that of the 20-odd lines available for funding, researchers have so far depended primarily on just 2 of the oldest human embryonic stem cell lines1. Read more
At a board meeting for the California Institute of Regenerative Medicine yesterday, President Alan Trounson said the organization needed to prepare to move laboratory research into clinical trials within four years. That, he said, means hiring a new vice president with corporate experience to work closely with industry and regulatory agencies and shepherd the work of the soon-to-be-funded disease teams. Read more